Free Trial

Warby Parker (WRBY) Competitors

Warby Parker logo
$23.50 -0.25 (-1.03%)
As of 03:20 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

WRBY vs. PEN, STVN, GKOS, BLCO, SLNO, IRTC, INSP, TMDX, NVST, and PRCT

Should you be buying Warby Parker stock or one of its competitors? The main competitors of Warby Parker include Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), Inspire Medical Systems (INSP), TransMedics Group (TMDX), Envista (NVST), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical equipment" industry.

Warby Parker vs. Its Competitors

Penumbra (NYSE:PEN) and Warby Parker (NYSE:WRBY) are both mid-cap medical equipment companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, dividends, analyst recommendations, institutional ownership and media sentiment.

Penumbra presently has a consensus target price of $300.07, suggesting a potential upside of 18.98%. Warby Parker has a consensus target price of $22.75, suggesting a potential downside of 3.21%. Given Penumbra's stronger consensus rating and higher probable upside, equities analysts clearly believe Penumbra is more favorable than Warby Parker.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Penumbra
0 Sell rating(s)
3 Hold rating(s)
13 Buy rating(s)
2 Strong Buy rating(s)
2.94
Warby Parker
0 Sell rating(s)
9 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.53

In the previous week, Penumbra had 12 more articles in the media than Warby Parker. MarketBeat recorded 23 mentions for Penumbra and 11 mentions for Warby Parker. Warby Parker's average media sentiment score of 1.59 beat Penumbra's score of 0.88 indicating that Warby Parker is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Penumbra
7 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Warby Parker
8 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Penumbra has higher revenue and earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Penumbra$1.24B7.88$14.01M$1.06237.93
Warby Parker$771.32M3.18-$20.39M-$0.12-195.88

Penumbra has a net margin of 3.41% compared to Warby Parker's net margin of -1.79%. Penumbra's return on equity of 11.14% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Penumbra3.41% 11.14% 8.40%
Warby Parker -1.79%-2.48%-1.29%

88.9% of Penumbra shares are held by institutional investors. Comparatively, 93.2% of Warby Parker shares are held by institutional investors. 5.0% of Penumbra shares are held by company insiders. Comparatively, 18.2% of Warby Parker shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Penumbra has a beta of 0.47, meaning that its share price is 53% less volatile than the S&P 500. Comparatively, Warby Parker has a beta of 2.09, meaning that its share price is 109% more volatile than the S&P 500.

Summary

Penumbra beats Warby Parker on 13 of the 17 factors compared between the two stocks.

Get Warby Parker News Delivered to You Automatically

Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WRBY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WRBY vs. The Competition

MetricWarby ParkerCONS PD IndustryStaples SectorNYSE Exchange
Market Cap$2.45B$32.36B$15.92B$20.77B
Dividend YieldN/A2.59%3.12%3.60%
P/E Ratio-195.7631.7519.8127.79
Price / Sales3.181.8045.7867.16
Price / Cash70.9316.6814.8923.29
Price / Book7.028.376.074.52
Net Income-$20.39M$1.19B$690.35M$993.24M
7 Day Performance-3.60%-5.11%-3.17%-2.39%
1 Month Performance7.13%2.28%1.40%2.20%
1 Year Performance47.00%-4.57%-0.24%8.33%

Warby Parker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WRBY
Warby Parker
3.0098 of 5 stars
$23.51
-1.0%
$22.75
-3.2%
+48.4%$2.45B$771.32M-195.763,780Positive News
Analyst Forecast
Gap Up
PEN
Penumbra
4.5635 of 5 stars
$229.90
-1.4%
$305.07
+32.7%
+27.5%$9.03B$1.19B216.894,500Trending News
Earnings Report
Analyst Forecast
Gap Up
STVN
Stevanato Group
N/A€25.77
-2.8%
N/A+30.8%€7.80B€1.19B50.535,521Upcoming Earnings
GKOS
Glaukos
4.3232 of 5 stars
$94.80
+0.5%
$134.67
+42.1%
-21.5%$5.39B$383.48M-40.00780Positive News
BLCO
Bausch + Lomb
2.0344 of 5 stars
$14.47
+1.0%
$15.45
+6.8%
-12.3%$5.07B$4.79B-14.0513,500Trending News
Earnings Report
SLNO
Soleno Therapeutics
4.3433 of 5 stars
$85.25
-1.4%
$108.70
+27.5%
+79.4%$4.36BN/A-18.4530Positive News
Upcoming Earnings
IRTC
iRhythm Technologies
1.013 of 5 stars
$137.11
+2.2%
$137.30
+0.1%
+54.4%$4.28B$591.84M-43.672,000Upcoming Earnings
INSP
Inspire Medical Systems
4.8741 of 5 stars
$130.72
+1.4%
$208.55
+59.5%
-2.8%$3.80B$802.80M60.241,246Positive News
Upcoming Earnings
TMDX
TransMedics Group
1.8863 of 5 stars
$105.24
-2.7%
$129.88
+23.4%
-24.6%$3.66B$441.54M77.38210News Coverage
NVST
Envista
2.7591 of 5 stars
$20.73
-0.3%
$20.23
-2.4%
+23.8%$3.53B$2.51B-3.1712,300Positive News
Upcoming Earnings
Analyst Forecast
PRCT
PROCEPT BioRobotics
2.7013 of 5 stars
$54.08
-2.9%
$84.13
+55.6%
-13.7%$3.08B$224.50M-31.81430Upcoming Earnings

Related Companies and Tools


This page (NYSE:WRBY) was last updated on 7/30/2025 by MarketBeat.com Staff
From Our Partners